The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Carlo Pozzilli

Department of Neurology and Psychiatry

Multiple Sclerosis Centre

S. Andrea Hospital

'La Sapienza' University Rome

Italy

[email]@uniroma1.it

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Neurology and Psychiatry, Multiple Sclerosis Centre, S. Andrea Hospital, 'La Sapienza' University Rome, Italy. 2012
  • University Rome, Department of Neurological Sciences, La Sapienza University, S. Andrea Hospital, Italy. 2005 - 2011
  • La Sapienza University, S. Andrea Hospital, Multiple Sclerosis Centre, Department of Neurological Sciences, Italy. 2010
  • S. Andrea Hospital, La Sapienza University, Via di Grottarossa, 1035, 00189, Italy. 2008
  • Department of Neurological Sciences, University La Sapienza, Italy. 2002 - 2004

References

  1. Quality of life and depression in multiple sclerosis patients: longitudinal results of the BetaPlus study. Pozzilli, C., Schweikert, B., Ecari, U., Oentrich, W., Bugge, J.P. J. Neurol. (2012) [Pubmed]
  2. Supportive strategies to improve adherence to IFN beta-1b in Multiple Sclerosis--results of the BetaPlus observational cohort study. Pozzilli, C., Schweikert, B., Ecari, U., Oentrich, W. J. Neurol. Sci. (2011) [Pubmed]
  3. Treating multiple sclerosis with fingolimod or intramuscular interferon. Pozzilli, C., Prosperini, L., Borriello, G. Expert. Opin. Pharmacother (2010) [Pubmed]
  4. Clinical markers of therapeutic response to disease modifying drugs. Pozzilli, C., Prosperini, L. Neurol. Sci. (2008) [Pubmed]
  5. Interferon after 10 years in patients with multiple sclerosis. Pozzilli, C., Prosperini, L., Sbardella, E., Paolillo, A. Neurol. Sci. (2006) [Pubmed]
  6. Post-marketing survey on clinical response to interferon beta in relapsing multiple sclerosis: the Roman experience. Pozzilli, C., Prosperini, L., Sbardella, E., De Giglio, L., Onesti, E., Tomassini, V. Neurol. Sci. (2005) [Pubmed]
  7. Relationship between emotional distress in caregivers and health status in persons with multiple sclerosis. Pozzilli, C., Palmisano, L., Mainero, C., Tomassini, V., Marinelli, F., Ristori, G., Gasperini, C., Fabiani, M., Battaglia, M.A. Mult. Scler. (2004) [Pubmed]
  8. Monthly corticosteroids decrease neutralizing antibodies to IFNbeta1 b: a randomized trial in multiple sclerosis. Pozzilli, C., Antonini, G., Bagnato, F., Mainero, C., Tomassini, V., Onesti, E., Fantozzi, R., Galgani, S., Pasqualetti, P., Millefiorini, E., Spadaro, M., Dahlke, F., Gasperini, C. J. Neurol. (2002) [Pubmed]
  9. Epidemiology and current treatment of multiple sclerosis in Europe today. Pozzilli, C., Romano, S., Cannoni, S. J. Rehabil. Res. Dev (2002) [Pubmed]
  10. Home based management in multiple sclerosis: results of a randomised controlled trial. Pozzilli, C., Brunetti, M., Amicosante, A.M., Gasperini, C., Ristori, G., Palmisano, L., Battaglia, M. J. Neurol. Neurosurg. Psychiatr. (2002) [Pubmed]
 
WikiGenes - Universities